The Origin and Nature of Tightly Clustered Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution
Recurrent submicroscopic deletions in genes affecting key cellular pathways are a hallmark of pediatric acute lymphoblastic leukemia (ALL). To gain more insight into the mechanism underlying these deletions, we have studied the occurrence and nature of abnormalities in one of these genes, the B-cell translocation gene 1 (BTG1), in a large cohort of pediatric ALL cases. BTG1 was found to be exclusively affected by genomic deletions, which were detected in 65 out of 722 B-cell precursor ALL (BCP-ALL) patient samples (9%), but not in 109 T-ALL cases. Eight different deletion sizes were identified, which all clustered at the telomeric site in a hotspot region within the second (and last) exon of the BTG1 gene, resulting in the expression of truncated BTG1 read-through transcripts. The presence of V(D)J recombination signal sequences at both sites of virtually all deletions strongly suggests illegitimate RAG1/RAG2-mediated recombination as the responsible mechanism. Moreover, high levels of histone H3 lysine 4 trimethylation (H3K4me3), which is known to tether the RAG enzyme complex to DNA, were found within the BTG1 gene body in BCP-ALL cells, but not T-ALL cells. BTG1 deletions were rarely found in hyperdiploid BCP-ALLs, but were predominant in other cytogenetic subgroups, including the ETV6-RUNX1 and BCR-ABL1 positive BCP-ALL subgroups. Through sensitive PCR-based screening, we identified multiple additional BTG1 deletions at the subclonal level in BCP-ALL, with equal cytogenetic distribution which, in some cases, grew out into the major clone at relapse. Taken together, our results indicate that BTG1 deletions may act as “drivers” of leukemogenesis in specific BCP-ALL subgroups, in which they can arise independently in multiple subclones at sites that are prone to aberrant RAG1/RAG2-mediated recombination events. These findings provide further evidence for a complex and multiclonal evolution of ALL.
Vyšlo v časopise:
The Origin and Nature of Tightly Clustered Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002533
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002533
Souhrn
Recurrent submicroscopic deletions in genes affecting key cellular pathways are a hallmark of pediatric acute lymphoblastic leukemia (ALL). To gain more insight into the mechanism underlying these deletions, we have studied the occurrence and nature of abnormalities in one of these genes, the B-cell translocation gene 1 (BTG1), in a large cohort of pediatric ALL cases. BTG1 was found to be exclusively affected by genomic deletions, which were detected in 65 out of 722 B-cell precursor ALL (BCP-ALL) patient samples (9%), but not in 109 T-ALL cases. Eight different deletion sizes were identified, which all clustered at the telomeric site in a hotspot region within the second (and last) exon of the BTG1 gene, resulting in the expression of truncated BTG1 read-through transcripts. The presence of V(D)J recombination signal sequences at both sites of virtually all deletions strongly suggests illegitimate RAG1/RAG2-mediated recombination as the responsible mechanism. Moreover, high levels of histone H3 lysine 4 trimethylation (H3K4me3), which is known to tether the RAG enzyme complex to DNA, were found within the BTG1 gene body in BCP-ALL cells, but not T-ALL cells. BTG1 deletions were rarely found in hyperdiploid BCP-ALLs, but were predominant in other cytogenetic subgroups, including the ETV6-RUNX1 and BCR-ABL1 positive BCP-ALL subgroups. Through sensitive PCR-based screening, we identified multiple additional BTG1 deletions at the subclonal level in BCP-ALL, with equal cytogenetic distribution which, in some cases, grew out into the major clone at relapse. Taken together, our results indicate that BTG1 deletions may act as “drivers” of leukemogenesis in specific BCP-ALL subgroups, in which they can arise independently in multiple subclones at sites that are prone to aberrant RAG1/RAG2-mediated recombination events. These findings provide further evidence for a complex and multiclonal evolution of ALL.
Zdroje
1. PuiCHRellingMVDowningJR 2004 Acute lymphoblastic leukemia. N Engl J Med 350 1535 1548
2. MullighanCGGoorhaSRadtkeIMillerCBCoustan-SmithE 2007 Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446 758 764
3. KuiperRPSchoenmakersEFReijmersdal vanSVHehir-KwaJYGeurts van KesselA 2007 High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21 1258 1266
4. TsuzukiSKarnanSHoribeKMatsumotoKKatoK 2007 Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization. Cancer Sci 98 698 706
5. KuiperRPWaandersEvan der VeldenVHJvan ReijmersdalSVVenkatachalamR 2010 IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia 24 1258 1264
6. WaandersEvan der VeldenVHJvan der SchootCEvan LeeuwenFNvan ReijmersdalSV 2011 Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia 25 254 258
7. HarveyRCMullighanCGWangXDobbinKKDavidsonGS 2010 Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116 4874 4884
8. Van GalenJCKuiperRPvanELLeversMTijchonE 2010 BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. Blood 115 4810 4819
9. WinklerGS 2010 The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222 66 72
10. MorinRDMendez-LagoMMungallAJGoyaRMungallKL 2011 Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476 298 303
11. LinWJGaryJDYangMCClarkeSHerschmanHR 1996 The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271 15034 15044
12. RouaultJPPrevotDBerthetCBirotAMBillaudM 1998 Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem 273 22563 22569
13. BussonMCarazoASeyerPGrandemangeSCasasF 2005 Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24 1698 1710
14. PrevotDVoeltzelTBirotAMMorelAPRostanMC 2000 The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem 275 147 153
15. LieberMRMaYPannickeUSchwarzK 2003 Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4 712 720
16. JungDGiallourakisCMostoslavskyRAltFW 2006 Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 24:541–70 541 570
17. StavnezerJGuikemaJESchraderCE 2008 Mechanism and regulation of class switch recombination. Annu Rev Immunol 26:261–92 261 292
18. MarculescuRLeTSimonPJaegerUNadelB 2002 V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J Exp Med 195 85 98
19. MullighanCGMillerCBRadtkeIPhillipsLADaltonJ 2008 BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453 110 114
20. IacobucciIStorlazziCTCilloniDLonettiAOttavianiE 2009 Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 114 2159 2167
21. MullighanCGPhillipsLASuXMaJMillerCB 2008 Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322 1377 1380
22. ZhangJMullighanCGHarveyRCWuGChenX 2011 Key pathways are frequently mutated in high risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118 3080 3087
23. GreavesM 2010 Cancer stem cells: back to Darwin? Semin Cancer Biol 20 65 70
24. AndersonKLutzCvan DelftFWBatemanCMGuoY 2011 Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469 356 361
25. NottaFMullighanCGWangJCPoepplADoulatovS 2011 Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469 362 367
26. MatthewsAGKuoAJRamon-MaiquesSHanSChampagneKS 2007 RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450 1106 1110
27. McMurryMTKrangelMS 2000 A role for histone acetylation in the developmental regulation of VDJ recombination. Science 287 495 498
28. ShimazakiNTsaiAGLieberMR 2009 H3K4me3 stimulates the V(D)J RAG complex for both nicking and hairpinning in trans in addition to tethering in cis: implications for translocations. Mol Cell 34 535 544
29. ThandlaSPPloskiJERaza-EgilmezSZChhalliyilPPBlockAW 1999 ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93 293 299
30. NumataMSaitoSNagataK 2010 RAG-dependent recombination at cryptic RSSs within TEL-AML1 t(12;21)(p13;q22) chromosomal translocation region. Biochem Biophys Res Commun 402 718 724
31. ScoreJCalasanzMJOttmanOPaneFYehRF 2010 Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation. Leukemia 24 1742 1750
32. Van DelftFWHorsleySColmanSAndersonKBatemanC 2011 Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood 117 6247 6254
33. NovaraFBeriSBernardoMEBellazziRMaloviniA 2009 Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood. Hum Genet 126 511 520
34. RaschkeSBalzVEfferthTSchulzWAFlorlAR 2005 Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 42 58 67
35. Van VlierberghePvan GrotelMBeverlooHBLeeCHelgasonT 2006 The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108 3520 3529
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Gene Expression and Stress Response Mediated by the Epigenetic Regulation of a Transposable Element Small RNA
- Contrasting Properties of Gene-Specific Regulatory, Coding, and Copy Number Mutations in : Frequency, Effects, and Dominance
- Homeobox Genes Critically Regulate Embryo Implantation by Controlling Paracrine Signaling between Uterine Stroma and Epithelium
- Nondisjunction of a Single Chromosome Leads to Breakage and Activation of DNA Damage Checkpoint in G2